Literature DB >> 26316604

Bone Marrow Cell Therapy for Ischemic Heart Disease: The Never Ending Story.

Giulio Pompilio1, Patrizia Nigro1, Beatrice Bassetti1, Maurizio C Capogrossi2.   

Abstract

Keywords:  Editorial; bone marrow; cardiac cell therapy; ischemic heart disease; meta-analysis

Mesh：

Year:  2015        PMID： 26316604     DOI： 10.1161/CIRCRESAHA.115.307184

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  3 in total

Review 1.  Heart regeneration: 20 years of progress and renewed optimism.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Dev Cell       Date:  2022-02-28       Impact factor: 12.270

2.  Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO).

Authors:  Beatrice Bassetti; Corrado Carbucicchio; Valentina Catto; Elisa Gambini; Erica Rurali; Alberto Bestetti; Giuseppe Gaipa; Daniela Belotti; Fabrizio Celeste; Matteo Parma; Stefano Righetti; Lorenza Biava; Maurizio Arosio; Alice Bonomi; Piergiuseppe Agostoni; Paolo Scacciatella; Felice Achilli; Giulio Pompilio
Journal:  Stem Cell Res Ther       Date:  2018-09-14       Impact factor: 6.832

3.  Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction.

Authors:  Bo-Fang Zhang; Hong Jiang; Jing Chen; Qi Hu; Shuo Yang; Xiao-Pei Liu
Journal:  J Cell Physiol       Date:  2019-04-14       Impact factor: 6.384
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.